BAGNARDI VINCENZO
- U07, Floor: 4, Room: 4059
Publications
Vicini, E., Galimberti, V., Leonardi, M., Kahler-Ribeiro-Fontana, S., Polizzi, A., Petitto, S., et al. (2025). Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients. BREAST CANCER RESEARCH AND TREATMENT, 210(3), 661-672 [10.1007/s10549-024-07604-3]. Detail
Conforti, F., Nekljudova, V., Sala, I., Ascari, R., Solbach, C., Untch, M., et al. (2025). Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1441-1452 [10.1200/JCO-24-01360]. Detail
Nicosia, L., Mariano, L., Mallardi, C., Sorce, A., Frassoni, S., Bagnardi, V., et al. (2025). Influence of Breast Density and Menopausal Status on Background Parenchymal Enhancement in Contrast-Enhanced Mammography: Insights from a Retrospective Analysis. CANCERS, 17(1) [10.3390/cancers17010011]. Detail
Leonardi, M., Arculeo, S., Frassoni, S., Zerella, M., Gerardi, M., Fodor, C., et al. (2025). Hypofractionated Partial Breast Reirradiation in the Conservative Retreatment of Breast Cancer Local Recurrence. PRACTICAL RADIATION ONCOLOGY, 15(1 (January-February, 2025)), 31-47 [10.1016/j.prro.2024.07.003]. Detail
Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 117(8), 1557-1564 [10.1093/jnci/djaf049]. Detail